Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Children With High Grade Glioma
NCT00003535Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Apr 1994
- Primary completion
- Jan 1998
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in high-grade glioma (HGG), sponsored by Burzynski Research Institute. Started Apr 1994; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00003535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003535.